Results 161 to 170 of about 3,132 (216)

Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration. [PDF]

Clin Ophthalmol
Ahmed E, Goodchild C, Bisoukis A, Salvatore S.   +3 more
europepmc   +1 more source

Faricimab for choroidal neovascular membrane secondary to choroidal osteoma: A case report. [PDF]

J Int Med Res
Al Adel F, Alnfaiei JS, Alzahrani AA, Alotaibi WN.   +3 more
europepmc   +1 more source

A novel Tie2xVEGF bispecific antibody fusion demonstrates enhanced therapeutic efficacy through direct Tie2 activation and VEGF neutralization. [PDF]

J Transl Med
Kwon MG, Kim SJ, Lee K, Song JH, Lee J, Kim I, Min JK, Kwon YG, Lee DG, Lee J, Lee NK.   +10 more
europepmc   +1 more source

Aflibercept and Faricimab Equipotently Restore Endothelial Barrier Function. [PDF]

Invest Ophthalmol Vis Sci
Strunz T, Rao M, Prinz F, Toedling J, Lesche R, Mielke J, Tetzner R, Lange C, Brunck L.   +8 more
europepmc   +1 more source

Intravitreal Faricimab for Retinal Vein Occlusion: Real-World Outcomes from the Multicenter FARTURK-RVO Study in Türkiye. [PDF]

Ophthalmol Ther
Akkan F, Görgün E, Erden B, Bardak YK, Şerif N, Öztürk M, Çelik E, Bölükbaşı S, İpek ŞC, Uzundede T, Karataş G, Karapapak M, Özal E, Uyar OM, Cömerter D, Alp MN, Ermiş S, Korkmaz A, Arıcı M, Karataş ME, Yenerel NM, Artunay HÖ, Önder-Tokuç E, Karabaş VL, Ünal M, Kapran Z, Özdemir H, Çakır A.   +27 more
europepmc   +1 more source

Real-world outcomes of faricimab in treatment-naïve patients with neovascular age-related macular degeneration. [PDF]

BMC Ophthalmol
Chang W, Kim J, Jeon J, Park S.
europepmc   +1 more source

Multimodal imaging and intravitreal faricimab for polypoidal choroidal vasculopathy associated with a choroidal nevus in genetically confirmed Usher syndrome type 2: a case report. [PDF]

BMC Ophthalmol
Kim J, Choi J, Kim K, Yu SY.
europepmc   +1 more source

The Short-Term Outcomes of Intravitreal Faricimab for Treatment-Naïve and -Refractory Neovascular Age-Related Macular Degeneration: A Real-World Study. [PDF]

Medicina (Kaunas)
Chang HL, Wang LU, Huang TL, Chang PY, Ho WT, Hsu YR, Chen FT, Chen YJ, Lin CD, Wang JK.   +9 more
europepmc   +1 more source

A Matching-Adjusted Comparison of Faricimab and Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.

Ophthalmic Res
Lim JI, Leng T, Siedlecki J, Lupidi M, Wells JA, Keane PA, Nudleman E, Mar F, Gibson K, Margaron P, Tabano D, Bührer C, Holekamp N.   +12 more
europepmc   +1 more source